Scheibenbogen, C.; Sotzny, F.; Hartwig, J.; Bauer, S.; Freitag, H.; Wittke, K.; Doehner, W.; Scherbakov, N.; Loebel, M.; Grabowski, P.
Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study. J. Clin. Med. 2021, 10, 2420.
https://doi.org/10.3390/jcm10112420
AMA Style
Scheibenbogen C, Sotzny F, Hartwig J, Bauer S, Freitag H, Wittke K, Doehner W, Scherbakov N, Loebel M, Grabowski P.
Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study. Journal of Clinical Medicine. 2021; 10(11):2420.
https://doi.org/10.3390/jcm10112420
Chicago/Turabian Style
Scheibenbogen, Carmen, Franziska Sotzny, Jelka Hartwig, Sandra Bauer, Helma Freitag, Kirsten Wittke, Wolfram Doehner, Nadja Scherbakov, Madlen Loebel, and Patricia Grabowski.
2021. "Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study" Journal of Clinical Medicine 10, no. 11: 2420.
https://doi.org/10.3390/jcm10112420
APA Style
Scheibenbogen, C., Sotzny, F., Hartwig, J., Bauer, S., Freitag, H., Wittke, K., Doehner, W., Scherbakov, N., Loebel, M., & Grabowski, P.
(2021). Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study. Journal of Clinical Medicine, 10(11), 2420.
https://doi.org/10.3390/jcm10112420